Natural killer (NK) cells kill normal and transformed hematopoietic cells that lack expression of major histocompatibility complex (MHC) class I antigens. Lysis of HLA-negative Epstein Barr virus-transformed B lymphoblastoid call lines (B-LCL) by human NK cell clones can be inhibited by transfection of the target cells with certain HLA-A, -I3, or -C alleles. NK cell clones established from an individual demonstrate donal heterogeneity in HLA recognition and a single NK clone can recognize multiple alleles. We describe a potential human NK cell receptor (NKB1) for certain HLA-B alleles (e.g., HLA-B*5101 and-B*5801) identified by the mAb Dxg. NKB1 is a 70-kD glycoprotein that is expressed on a subset of NK cells and NK cell clones. DX9 monoclonal antibody (mAb) specifically inhibits the interaction between NK cell clones and B-LCL targets transfected with certain HLA-B alleles, but does not affect recognition of HLA-A or HLA-C antigens. An individual NK cell clone can independently recognize B-LCL targets transfected with HLA-B or HLA-C antigens; however, DX9 mAb only affects interaction with transfectants expressing certain HLA-B alleles. These findings demonstrate the existence of NK cell receptors involved in the recognition of HLA-B and imply the presence of multiple receptors for MHC on an individual NK clone.
N
'K cells are lymphocytes distinct from T and B cells that mediate cell-mediated cytotoxicity and secrete cytokines after immune stimulation (1) . The specific receptors involved in NK cell recognition and activation remain undefined; nonetheless, it is becoming increasingly clear that both triggering and inhibitory molecules dictate their lytic specificity NK cell effector function presumably involves a positive signal that initiates cytotoxicity and cytokine production. In the case of antibody-dependent cellular cytotoxicity, the positive signal is generated by the interaction between the Ig-coated target and CD16 (Fc',/RIII) on the NK cell (2) . The membrane receptors responsible for initiating lysis of transformed or virus-infected cells in the absence of specific Ig have not been identified.
NK cell-mediated cytotoxicity is also regulated by inhibitory signals. K~"re et al. (3, 4) initially observed that certain murine tumor variants lacking H-2 antigens were more susceptible to NK lysis than the parental tumor cells expressing high levels of H-2. Similarly, when MHC class I molecules were transfected into human HLA class I-deficient B lymphoblastoid cell lines (B-LCL), 1 the transfectants were less 1 Abbreviation used in this paper: B-LCL, B lymphoblastoid cell lines. susceptible to NK cell lysis than the parental lines (5, 6) . Analysis of an extensive panel of NK cell clones revealed that human NK cells have the ability to recognize multiple HLA-A, -B, and -C alleles (7) . Two models that could account for this phenomenon have been proposed: (a) target interference and (b) effector inhibition (3, 4) . The target interference model postulates that target cell MHC class I molecules mask antigens that stimulate NK lysis; the effector inhibition model proposes that target cell MHC class I molecules interact with specific receptors on NK cells, thereby transmitting a negative signal that prevents the initiation of cytolysis. Recent findings support the latter model (8) .
Karlhofer et al. (8) have identified a class I MHC receptor, Ly-49, that is expressed on a subset ofmurine NK cells. The interaction between Ly-49 on the NK cell and H-2D a molecules on target cells prevents NK cell-mediated cytotoxicity. Ly-49 is a type II membrane glycoprotein of the C-type lectin superfamily. Ly-49 and a family of at least five related genes are on mouse chromosome 6 (9-11). One member of the Ly-49 family, SWSE6, (12) appears to be involved in mediating the rejection of allogeneic bone marrow cells (13) . SW5E6 and Ly-49 are expressed as disulfide-linked homodimers; as yet, there is no evidence for heterodimers between members of the Ly-49 family. Human NK cell receptors for HLA have yet to be characterized fully, although Colonna et al. (14) and Ciccone et al. (15) describe two antigens expressed on NK subsets that appear to correlate with recognition of HLA-C. Our studies, however, have demonstrated that NK clones recognize not only HLA-C, but also HLA-A and HLA-B (7), suggesting the existence of additional receptors. In the present study, we describe an NK cell receptor involved in the recognition of HLA-B.
Materials and Methods
NK Clones. Peripheral blood from healthy individuals was purchased from the Stanford Blood Bank (Stanford, CA). NK cell clones (CD3-, CD56 +) were established using the culture conditions described by Yssel et al. (16) .
raAbs andFlow Cytometry. mAbs were provided generously by Becton Dickinson Immunocytometry Systems (Mountain View, CA). Cy-chrome TM conjugated anti-CD3 was purchased from PharMingen (San Diego, CA). The DX9 (IgG1) hybridoma was generated by immunizing BALB/c mice with the human NK clone VL186-1 (CD3-, CD16 +, CD56 +) and fusing their splenocytes with the Sp2/0 myeloma cell line. Fab and F(ab')2 fragments were prepared by digesting DX9 IgG with immobilized papain (5 mg IgG in 5 ml of 20 mM NaHzPO~, 20 mM cysteine-HC1 buffer, pH 7.0, with 1 ml immobilized papain for 7 h at 37~ or immobilized pepsin (10 mg IgG in 10 ml of 0.2 M sodium citrate, 0.15 M NaCI buffer, pH 3.5, with 2.5 ml immobilized pepsin for 2 h at 37 ~ (Pierce, Rockford, IL), respectively, and afterwards removing residual intact mAb by protein A affinity chromatography. Purity of the F(ab')2 and Fab fragments was determined by SDS-PAGE. Methods of immunofluorescent staining and flow cytometry have been described previously (17) .
Biochemistry. Cells were labded with nsI using lactoperoxidase/glucose oxidase or with [32p]orthophosphate (Amersham Corp., Arlington Heights, IL) (18) . Cells were lysed in Tris-buffered saline (50 mM Tris, 15 mM NaCI, pH 8.0) containing 1% NP-40 and protease inhibitors (1 mM PMSF and 20 Kallikrein inhibitor U/m1 aprotinin) and phosphatase inhibitors (1 mM EGTA, 10 mM NaF, 1 mM Na4PzO7, 0.1 mM ~-glycerophosphate, 1 mM Na3VO4) or 20 mM triethanolamine/150 mM NaCI buffer (pH 7.8) containing 1% digitonin (CalBiochem-Novabiochem Corp., La Jolla, CA) and 0.12% Triton X-100 (Sigma Chemical Co., St. Louis, MO) with protease inhibitors. NKB1 antigen was immunoprecipitated using the method described previously (18) . NKB1 glycoprotein was treated with neuraminidase (Sigma Chemical Co.), O-glycanase (Genzyme, Boston, /VIA), and N-glycosidase F (Boehringer Mannheim Corp., Indianapolis, IN) using the conditions recommended by the manufacturers. Samphs were analyzed by SDS-PAGE.
Cytotoxicity Assays. NK cell-mediated cytotoxicity was measured using a 4-h SlCr radioisotope release assay (2) . Assays were performed using an effector/target ratio of 6:1 in the presence and absence of DX9 mAb (5/~g/ml). -Cw*0304, -Cw*0401, -Cw*0801, and -Cw'1503 were generated as described previously (7).
Results and Discussion
Generation and Characterization of DX9 mAt~ Whereas many NK cell clones and polyclonal NK populations kill the MHC class I-deficient B-LCL C1R and 721.221, transfection of these cell lines with certain alleles of HLA-A, -B, or -C results in protection from NK cell lysis (5, 6, 7) . In particular, the products of certain HLA-B alleles (e.g., HLA-B'5101, -B'5801) frequently protected against lysis by NK clones (7) . To identify NK call receptors for HLA, mAbs were generated against an NK done (VL186-1) that was strongly inhibited by the expression of HLA-B*5801 on the surface of the C1R B-LCL target (7). mAbs were therefore sdected for their capacity to permit lysis of the HLA-B*5801 C1R transfectant and in this manner DX9 mAb was isolated. Whereas NK done VL186-1 failed to kill HLA-B*5801-transfected C1R (0% cytotoxicity), in the presence of mAb DX9 64% lysis of HLA-B*5801-transfected CIR was observed. The DX9 mAb reacted with a molecule on the surface of NK done VL186-1, but failed to stain the HLA-B*5801 transfected C1R, indicating that the effect was due to interaction with the NK effector cell and not the target.
The antigen recognized by DX9 mAb, designated NKB1, was found to be expressed on the surface of a subset of Fig. 2 and Table 1 ). By contrast, killing of the untransfected HLAdeficient EBV transformed B-LCL cell lines 721.221 and C1R by NKB1 + NK clones was neither augmented nor inhibited by DX9 mAb (Fig. 2) . As shown in Fig. 3, F(ab')2 . The E/T ratio was 6:1. toxicity against certain HLA-B alleles, in addition to HLA-B'5801, but did not affect cytotoxicity against any of the HLA-C transfectants examined. Representative data obtained from experiments with two NKB1 + dones are shown in Fig, 2 and the results obtained from several NKB1-and NKB1 + NK clones are summarized in Table 1 . Whereas NKB1 + NK clones recognized and therefore failed to lyse transfectants expressing certain HLA-C alleles, including -Cw*0102, Cw*0301, -Cw*0304, -Cw*0401, -Cw*0801, and -Cw'1503, the presence of DX9 mAb had no effect on the target protection conferred by these molecules. This observation demonstrates that binding DX9 mAb to the NK clones need not interfere with the recognition of all HLA molecules, but only that of specific alleles.
Individual NK clones have the ability to recognize multiple alleles of HLA-B (7). Therefore, we examined the effect of DX9 mAb on NK cell-mediated lysis of B-LCL transThe DX9 mAb and its F(ab')2 and Fab fragments did not affect NK cellmediated lysis of the HLA-negative 721.221 EBV-LCL target cells (Fig,  2 and not shown). * + Indicates that the percent specific lysis of the HLA-transfected target cell was comparable with that of the parental cell line or substantially increased in the presence ofDX9 mAb. In all cases the lysis of the parental cell lines was 30% or greater. The data are a composite of several experiments. + -Indicates that the percent specific lysis of the HLA-transfected target cell was 50% or less than that of the parental cell line, i.e., the NK clone recognizes that particular HLA allele. s nd, not determined.
fectants expressing B*0702, -B'2705, -B'3505, -B'3701, -B'4801, -B'5101, -B'5401, or -B'5501. We observed that DX9 mAb reversed the protection conferred by HLA-B*5101 consistently, in addition to HLA-B*5801 ( Fig. 2 and Table  1 ). The DX9 mAb also affected recognition of HLA-B*2705. However, the protection conferred by -B'2705 was less than with -B'5101 or -B'5801 (Fig. 2) . Consistent with previous observations (7), NK clones recognizing -B*0702, -B'3505, -B'3701, -B'4801, -B'5401, or -B'5501 and the HLA-A alleles (-A*0201, -A*0211, -A*0301, -A'3601, -A'6801) were less frequent than NK clones recognizing -B'5801; however, preliminary studies indicate that DX9 mAb has little effect upon the lysis of the latter transfectants (not shown). Further analysis of NK clones that recognize these less frequently protective HLA-A and HLA-B alleles is required to exclude reactivity with these molecules. Certain NKB1-NK cell clones recognized HLA-B* 5801 and -B'5101, although as expected DX9 mAb failed to affect lysis of these transfectants. Therefore, whereas the results are compatible with the possibility that NKB1 is a receptor for HLA-B*5801 and -B'5101, they also suggest that additional receptors with this specificity are also present on NKB1-NK clones. NKB1 -NK clones may express a variant of the NKB1 molecule not recognized by the DX9 mAb or a distinct receptor that also recognizes HLA-B*5801 and -B'5101. There was no apparent bias in the recognition of HLA-A or HLA-C alleles by clones derived from either the NKB1-or NKB1 + NK subsets, suggesting the existence of independent receptors for HLA-A and HLA-C.
Structure of NKB1 Antigen. The DX9 mAb immunoprecipitates a 70-kD glycoprotein from 12SI-labeled NKB1 + NK cell clones that on SDS-PAGE gels migrates as a single species under both reducing and nonreducing conditions (Fig.  4) . Identical results were obtained using 1% NP-40 or 1% digitonin detergent for cell disruption. Treatment with neuraminidase slightly decreased the mobility of NKB1, indicating that the protein is sialated. Digestion of the NKB1 protein with Noglycanase reduced the apparent molecule weight to "~50 kD, demonstrating the presence of complex N-linked olignsaccharides. In contrast, endo-H and O-glycanase had no effect upon the mobility of the NKB1 protein. It should be noted that NKB1 + NK clones shown in Fig.  2 were derived from an HLA-B*5801 + donor. Thus, both the NKB1 receptor and its putative ligand HLA-B* 5801 can be expressed by the same NK done. Moreover, NKB1 + NK clones from an HLA-B*5801 + donor efficiently lysed the HLA-deficient B-LCL CIR, whereas no lysis of C1R.B*5801 was observed. These results indicate that if a "negative signal" is induced it is directional and target specific (i.e., the potential interaction of NKB1 with HLA-B on either the same or an adjacent NK clone does not prevent the lysis of a sus-ceptible target lacking HLA class I molecules). Therefore, the putative inhibitory signal sent through the NKB1 receptor does not irreversibly inactivate the NK cell. Recent studies using NK cell lines reactive with HLA-C also support the concept that bystander cells expressing inhibitory HLA alleles are unable to affect the interaction between an NK cell and a susceptible target (22) .
Further heterogeneity is introduced by the expression of NKB1 on only a subset of NK cells and the variable size of this subset in different individuals. A similar situation exists with expression of Ly-49 and 5E6, which are expressed only on a subset of NK cells in certain mouse strains (9, 13) . Similarly, the EB6 and GL183 antigens implicated in recognition of HLA-C are expressed only on partially overlapping subsets of human NK cells (23) .
Previous studies by Colonna et al. (14) have demonstrated a correlation between expression of EB6 and GL183 and target cell protection by HLA-C. From family studies and analysis of HLA-C transfectants, two NK target specificities (designated group 1 and group 2) corresponding to a dimorphic sequence motif at amino acids 77 and 80 of HLA-C alleles have been defined (14, 22, 24) . The NKB1 molecule is distinct both in class I HLA specificity and structure from EB6 and GL183. Certain NKB1 + NK clones have the ability to recognize HLA-C alleles of the group 1 or 2 specificities. EB6/GL183 and NKB1 are all structurally different from the murine Ly-49 receptors, which are disulfide-linked homodimers (9) . Furthermore, the 70-kD NKB1 glyeoprotein appears larger on SDS-PAGE than the EB6 and GL183 glycoprotdns, which migrate at 58 kD. Further understanding of the relationship between these various NK receptors will come from comparison of the sequences of the cloned genes. Nonethdess, the results are compatible with the existence of distinct NK receptors for HLA-B and HLA-C on a single NK done that function independently.
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